Tech Company Financing Transactions
Iktos Funding Round
Iktos, based in Paris, scored $16.5 million in funding from Debiopharm Innovation Fund, M Ventures and OMNES Capital.
Transaction Overview
Company Name
Announced On
3/9/2023
Transaction Type
Venture Equity
Amount
$16,502,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to expand its AI technology platform, launch Iktos Robotics, an AI-driven automated end-to-end drug discovery service, and extend the application of its solutions to biological products (peptides, antibodies, etc.).
Company Information
Company Status
Private & Independent
Industry
Artificial Intelligence
Mailing Address
65 rue de Prony
Paris, 75017
FR
Paris, 75017
FR
Phone
Website
Email Address
Overview
Iktos is an innovative company specializing in the development of artificial intelligence (AI) solutions applied to chemical research, more specifically medicinal chemistry and new drug design. The use of Iktos technology platform enables major productivity gains in upstream pharmaceutical R&D.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Yann Mathé
Chief Financial Officer
Stephane Milot
Chief Technical Officer
Nicolas Huu
Co-Founder
Quentin Perron
Browse more venture capital transactions:
Prev: 3/9/2023: Indra venture capital transaction
Next: 3/9/2023: NuVision venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs